Physician profile
Anthony C Munaco
NPI 1922068899
$2,250.45
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,793 · 2020: $415 · 2021: $42.09.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $367.01 | 2019-2021 | |
| Astellas Pharma US INC | $232.80 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $205.01 | 2019-2020 | |
| Amgen INC. | $192.23 | 2019-2020 | |
| Glaxosmithkline, LLC. | $187.46 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $183.08 | 2019-2020 | |
| Novo Nordisk INC | $175.11 | 2019-2020 | |
| Lilly USA, LLC | $134.39 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $111.84 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.57 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $59.32 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $54.19 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $50.48 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $45.30 | 2019-2020 | |
| Amarin Pharma, INC. | $41.33 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $41.31 | 2019 | |
| Amneal Pharmaceuticals LLC | $24.94 | 2019-2020 | |
| Esperion Therapeutics, INC. | $24.22 | 2021 | |
| Allergan, INC. | $22.81 | 2020 | |
| Eisai INC. | $12.05 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Munaco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.